Tech Company M&A Transactions
Oculeve Acquisition
Oculeve, operating out of San Francisco, was acquired by Allergan Plc. Allergan Plc said the transaction price was $125 million.
Transaction Overview
Company Name
Acquired By
Announced On
7/6/2015
Transaction Type
M&A
Amount
$125,000,000
M&A Terms
Allergan plc (NYSE: AGN), a leading global pharmaceutical company, and Oculeve, a development-stage medical device company focused on developing novel treatments for dry eye disease, today announced that they have entered into an agreement under which Allergan will acquire Oculeve in an all-cash transaction. Under the terms of the agreement, Allergan will acquire Oculeve for a $125 million upfront payment and commercialization milestone payments related to Oculeve's lead development program OD-01. The agreement also includes the acquisition of an additional earlier-stage dry eye device development program.
Company Information
Company Status
Acquired or Merged
Industry
Medical Devices & Instruments
Mailing Address
1082 Pennsylvannia Ave 409
San Francisco, CA 94107
USA
San Francisco, CA 94107
USA
Phone
Website
Email Address
Overview
Oculeve, Inc. is developing a novel treatment for Dry Eye, a disease affecting many millions of people worldwide. Oculeve was founded in the heart of Silicon Valley by an expert team of scientists, clinicians, engineers and business executives.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
Michael Ackermann
Browse more venture capital transactions:
Prev: 7/6/2015: Salsify venture capital transaction
Next: 7/6/2015: Pycno venture capital transaction
Share this article
Where The Data Comes From
Our team works diligently to report on all VC transactions involving tech companies. VC transactions reported here are sourced from company press releases and news coverage. The data comes to us via our partnership with VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs